Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-023198-21Phase 3Completed
Phase 3, randomised trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in HbA1c in participants with baseline HbA1c ≥ 7.5%. Started May 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-023198-21.